Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Merler, Stefano ^a   Ajelli, Marco ^a   Camilloni, Barbara ^c   Puzelli, Simona ^b   Bella, Antonino ^b   Rota, Maria Cristina ^b   Tozzi, Alberto Eugenio ^d   Muraca, Maurizio ^d   Meledandri, Marcello ^e   Iorio, Anna Maria ^c   Donatelli, Isabella ^b   Rizzo, Caterina ^b  

^a FONDAZIONE BRUNO KESSLER   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; HEMAGGLUTINATION INHIBITION TEST; HIGH RISK POPULATION; HUMAN; IMMUNITY; INFANT; INFECTION SENSITIVITY; ITALY; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; SEROLOGY; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INCIDENCE; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; ITALY; MALE; MIDDLE AGED; RISK;

EID: 84885074424     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074785     Document Type: Article

References (46)

1. World Health Organization (2009) Influenza-like illness in the United States and Mexico. Available: http://www.who.int/csr/don/2009_04_24/en/index.html. Accessed: 5 Sep 2013.
2. World Health Organization (2010) H1N1 in post-pandemic period. Available: http://www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/index.html. Accessed: 5 Sep 2013.
3. Rizzo C, Rota MC, Bella A, Giannitelli S, De SS, et al. (2010) Response to the 2009 influenza A (H1N1) pandemic in Italy. Euro Surveill 15:.
4. Jacobs JH, Archer BN, Baker MG, Cowling BJ, Heffernan RT, et al. (2012) Searching for sharp drops in the incidence of pandemic A/H1N1 influenza by single year of age. PLoS ONE 7: e42328.
5. Broberg E, Nicoll A, Mato-Gauci A, (2011) Seroprevalence to influenza A (H1N1) 2009 virus-where are we? Clin Vaccine Immunol 18: 1205-1212.
6. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet.
7. Adamson WE, McGregor EC, Kavanagh K, McMenamin J, McDonagh S, et al. (2011) Population exposure to a novel influenza A virus over three waves of infection. J Clin Virol 52: 300-303.
8. Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW, (2010) Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol 199: 117-121.
9. von Kries R, Weiss S, Falkenhorst G, Wirth S, Kaiser P, et al. (2011) Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany. PLoS ONE 6: e23955.
10. Dudareva S, Schweiger B, Thamm M, Hohle M, Stark K, et al. (2011) Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period. PLoS ONE 6: e21340.
11. Waalen K, Kilander A, Dudman SG, Krogh GH, Aune T, et al. (2010) High prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 15:.
12. Baguelin M, Hoschler K, Stanford E, Waight P, Hardelid P, et al. (2011) Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation. PLoS ONE 6: e17074.
13. Delangue J, Salez N, Ninove L, Kieffer A, Zandotti C, et al. (2012) Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population. Clin Microbiol Infect 18: 177-183.
14. Maltezou HC, Katerelos P, Mavrouli M, Lourida A, Routsias JG, et al. (2011) Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece. Vaccine 29: 6664-6669.
15. Reinheimer C, Allwinn R, Doerr HW, (2011) Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010. Infection 39: 101-104.
16. Reinheimer C, Doerr HW, Friedrichs I, Sturmer M, Allwinn R, (2012) H1N1v at a seroepidemiological glance: is the nightmare over? Eur J Clin Microbiol Infect Dis 31: 1467-1471.
17. Bone A, Guthmann JP, Assal A, Rousset D, Degeorges A, et al. (2012) Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France. PLoS ONE 7: e33056.
18. Morner A, Brave A, Kling AM, Kuhlmann-Berenzon S, Krook K, et al. (2012) Pandemic influenza A (H1N1) pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009. PLoS ONE 7: e53511.
19. Subelj V, Prosenc K, Socan M, (2012) Seroprevalence study of antibodies against influenza A (H1N1) 2009 virus after the second pandemic wave in Slovenia. Wien Klin Wochenschr 124: 177-180.
20. Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, et al. (2010) Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS ONE 5: e11601.
21. Achonu C, Rosella L, Gubbay JB, Deeks S, Rebbapragada A, et al. (2011) Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010. PLoS ONE 6: e26427.
22. Wagar LE, Rosella L, Crowcroft N, Lowcock B, Drohomyrecky PC, et al. (2011) Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination. PLoS ONE 6: e28063.
23. Bandaranayake D, Jacobs M, Baker M, Hunt D, Wood T, et al. (2011) The second wave of 2009 pandemic influenza A (H1N1) in New Zealand, January-October 2010. Euro Surveill 16:.
24. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, et al. (2010) Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS ONE 5: e12562.
25. Xu C, Bai T, Wang M, Chen T, Wang L, et al. (2012) Trends in seroprevalence of antibodies to pandemic influenza H1N1 (2009) virus among patients seeking care in China. Acta Virol 56: 329-335.
26. Riley S, Kwok KO, Wu KM, Ning DY, Cowling BJ, et al. (2011) Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med 8: e1000442.
27. Wu JT, Ho A, Ma ES, Lee CK, Chu DK, et al. (2011) Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data. PLoS Med 8: e1001103.
28. Van K, Hirve S, Koukounari A, Mounts AW (2013) Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A (H1N1) pdm09 serological studies from 19 countries. Influenza Other Respi Viruses.
29. Skowronski DM, Hottes TS, Janjua NZ, Purych D, Sabaiduc S, et al. (2010) Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 182: 1851-1856.
30. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, et al. (2009) Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 361: 2619-2627.
31. Merler S, Ajelli M, Pugliese A, Ferguson NM, (2011) Determinants of the spatiotemporal dynamics of the 2009 H1N1 pandemic in Europe: implications for real-time modelling. PLoS Comput Biol 7: e1002205.
32. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van K, et al. (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324: 1557-1561.
33. Rizzo C, Rota MC, Bella A, Alfonsi V, Declich S, et al. (2010) Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 28: 3558-3562.
34. Harmon M (1992) Laboratory dianosis of viral infections. In: Lenette H, editors. Influenza viruses. New York: Dekker. 515-534.
35. Istituto Superiore di Sanità (2010 November) Influnet Surveillance System. Available: http://www.iss.it/iflu. Accessed: 5 Sep 2013.
36. EMEA (1996) Note for Guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP 214/96:.
37. Mossong J, Hens N, Jit M, Beutels P, Auranen K, et al. (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5: e74.
38. Iozzi F, Trusiano F, Chinazzi M, Billari FC, Zagheni E, et al. (2010) Little Italy: an agent-based approach to the estimation of contact patterns- fitting predicted matrices to serological data. PLoS Comput Biol 6: e1001021.
39. Fumanelli L, Ajelli M, Manfredi P, Vespignani A, Merler S, (2012) Inferring the structure of social contacts from demographic data in the analysis of infectious diseases spread. PLoS Comput Biol 8: e1002673.
40. Ghani A, Baguelin M, Griffin J, Flasche S, van Hoek AJ, et al. (2009) The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom. PLoS Curr 1: RRN1130.
41. White LF, Wallinga J, Finelli L, Reed C, Riley S, et al. (2009) Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respi Viruses 3: 267-276.
42. Ajelli M, Merler S, Pugliese A, Rizzo C (2010) Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy. Epidemiol Infect 1-12.
43. Dorigatti I, Cauchemez S, Pugliese A, Ferguson NM, (2012) A new approach to characterising infectious disease transmission dynamics from sentinel surveillance: application to the Italian 2009-2010 A/H1N1 influenza pandemic. Epidemics 4: 9-21.
44. Adamson WE, Maddi S, Robertson C, McDonagh S, Molyneaux PJ, et al. (2010) 2009 pandemic influenza A (H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. Euro Surveill 15:.
45. Chen MI, Lee VJ, Lim WY, Barr IG, Lin RT, et al. (2010) 2009 influenza A (H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 303: 1383-1391.
46. Lim M, Bermingham SC, Edmunds A, Fragaszy JW, Harvey E, et al. (2010) Flu Watch - Community Burden of Influenza During Three Inter-pandemic Influenza Seasons and the Summer Wave of the 2009 H1N1 Pandemic in England - Implications for Interpretation of Surveillance. Conference Proceedings in Options for the Control of Influenza VII. Hong Kong, China Sept 2010.